[ESPR] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
06-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 24.32%
YoY- -56.31%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -9,238 -7,874 -9,689 -5,238 -6,921 -4,239 -2,775 123.44%
Tax 18 16 47 168 112 803 476 -88.80%
NP -9,238 -7,874 -9,689 -5,238 -6,921 -4,239 -2,775 123.44%
Tax Rate - - - - - - - -
Total Cost 9,238 7,874 9,689 5,238 6,921 4,239 2,775 123.44%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -0.60 -0.51 -0.63 -0.34 -0.47 -0.29 -0.29 62.58%
EPS Diluted -0.60 -0.51 -0.63 -0.34 -0.47 -0.29 -0.29 62.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.